Endobronchial valve therapy in patients with homogeneous emphysema results from the IMPACT study

American Journal of Respiratory and Critical Care Medicine

Volumn 194, Issue 9, 2016, Pages 1073-1082

  Valipour, Arschang ^a   Slebos, Dirk Jan ^b   Herth, Felix ^c   Darwiche, Kaid ^d   Wagner, Manfred ^e   Ficker, Joachim H ^e   Petermann, Christoph ^f   Hubner, Ralf Harto ^g   Stanzel, Franz ^h   Eberhardt, Ralf ^c  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e Department of Urology   (Germany)

^f Asklepios Klinik   (Germany)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h LUNGENKLINIK HEMER   (Germany)

Author keywords

Collateral ventilation; Endobronchial valve; Homogeneous emphysema; Lobar occlusion; Lung volume reduction

Indexed keywords

ADULT; ARTICLE; CHARTIS SYSTEM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEATH; DEVICE REMOVAL; DEVICE SAFETY; DEVICE THERAPY; DYSPNEA; ENDOBRONCHIAL VALVE; EXERCISE TOLERANCE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HEALTH CARE QUALITY; HOSPITAL INFECTION; HUMAN; INTENTION TO TREAT ANALYSIS; LENGTH OF STAY; LUNG EMPHYSEMA; LUNG FUNCTION; LUNG INFECTION; LUNG RESECTION; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MIDDLE AGED; MULTICENTER STUDY; PNEUMONIA; PNEUMOTHORAX; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENT LARYNGEAL NERVE PALSY; RESIDUAL VOLUME; RESPIRATORY DISTRESS; RESPIRATORY THERAPEUTIC DEVICE; RESPIRATORY TRACT DISEASE ASSESSMENT; SIX MINUTE WALK TEST; ST. GEORGE RESPIRATORY QUESTIONNAIRE; TREATMENT OUTCOME; VALVE; VALVE MIGRATION; ADVERSE EFFECTS; BRONCHUS; CLINICAL TRIAL; CROSSOVER PROCEDURE; DIAGNOSTIC IMAGING; PATHOLOGY; PROCEDURES; PROSTHESES AND ORTHOSES; PULMONARY EMPHYSEMA; X-RAY COMPUTED TOMOGRAPHY;

BRONCHI; CROSS-OVER STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PNEUMONECTOMY; PNEUMOTHORAX; PROSPECTIVE STUDIES; PROSTHESES AND IMPLANTS; PULMONARY EMPHYSEMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84994805949     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201607-1383OC     Document Type: Article

References (44)

1. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, Weinmann G, Wood DE; National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348:2059-2073.
2. Berger RL, Decamp MM, Criner GJ, Celli BR. Lung volume reduction therapies for advanced emphysema: an update. Chest 2010;138: 407-417.
3. McNulty W, Jordan S, Hopkinson NS. Attitudes and access to lung volume reduction surgery for COPD: a survey by the British Thoracic Society. BMJ Open Respir Res 2014;1:e000023.
4. Akuthota P, Litmanovich D, Zutler M, Boiselle PM, Bankier AA, Roberts DH, Celli BR, DeCamp MM, Berger RL. An evidence-based estimate on the size of the potential patient pool for lung volume reduction surgery. Ann Thorac Surg 2012;94:205-211.
5. Deslée G, Mal H, Dutau H, Bourdin A, Vergnon JM, Pison C, Kessler R, Jounieaux V, Thiberville L, Leroy S, et al.; REVOLENS Study Group. Lung volume reduction coil treatment vs usual care in patients with severe emphysema: the REVOLENS randomized clinical trial. JAMA 2016;315:175-184.
6. Sciurba FC, Criner GJ, Strange C, Shah PL, Michaud G, Connolly TA, Deslée G, Tillis WP, Delage A, Marquette CH, et al.; RENEW Study Research Group. Effect of endobronchial coils vs usual care on exercise tolerance in patients with severe emphysema: the RENEW randomized clinical trial. JAMA 2016;315:2178-2189.
7. Klooster K, Ten Hacken NH, Franz I, Kerstjens HA, van Rikxoort EM, Slebos DJ. Lung volume reduction coil treatment in chronic obstructive pulmonary disease patients with homogeneous emphysema: a prospective feasibility trial. Respiration 2014;88: 116-125.
8. Herth FJF, Slebos DJ, Rabe KF, Shah PL. Endoscopic lung volume reduction: an expert panel recommendation. Respiration 2016;91: 241-250.
9. Valipour A, Burghuber OC. An update on the efficacy of endobronchial valve therapy in the management of hyperinflation in patients with chronic obstructive pulmonary disease. Ther Adv Respir Dis 2015;9: 294-301.
10. Herth FJF, Noppen M, Valipour A, Leroy S, Vergnon JM, Ficker JH, Egan JJ, Gasparini S, Agusti C, Holmes-Higgin D, et al.; International VENT Study Group. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J 2012;39: 1334-1342.
11. Eberhardt R, Gompelmann D, Schuhmann M, Heussel CP, Herth FJ. Complete unilateral vs partial bilateral endoscopic lung volume reduction in patients with bilateral lung emphysema. Chest 2012; 142:900-908.
12. Sciurba FC, Ernst A, Herth FJF, Strange C, Criner GJ, Marquette CH, Kovitz KL, Chiacchierini RP, Goldin J, McLennan G; VENT Study Research Group. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med 2010;363: 1233-1244.
13. Davey C, Zoumot Z, Jordan S, McNulty WH, Carr DH, Hind MD, Hansell DM, Rubens MB, Banya W, Polkey MI, et al. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial. Lancet 2015; 386:1066-1073.
14. Klooster K, ten Hacken NHT, Hartman JE, Kerstjens HAM, van Rikxoort EM, Slebos DJ. Endobronchial valves for emphysema without interlobar collateral ventilation. N Engl J Med 2015;373: 2325-2335.
15. Valipour A, Herth FJ, Burghuber OC, Criner G, Vergnon JM, Goldin J, Sciurba F, Ernst A; VENT Study Group. Target lobe volume reduction and COPD outcome measures after endobronchial valve therapy. Eur Respir J 2014;43:387-396.
16. Eberhardt R, Heussel CP, Kreuter M, Weinheimer O, Herth FJ. [Bronchoscopic lung volume reduction in patients with severe homogeneous lung emphysema: a pilot study] [article in German]. Dtsch Med Wochenschr 2009;134:506-510.
17. Valipour A, Shah PL, Gesierich W, Eberhardt R, Snell G, Strange C, Barry R, Gupta A, Henne E, Bandyopadhyay S, et al. Patterns of emphysema heterogeneity. Respiration 2015;90:402-411.
18. Herth FJ, Eberhardt R, Gompelmann D, Ficker JH, Wagner M, Ek L, Schmidt B, Slebos DJ. Radiological and clinical outcomes of using Chartis™ to plan endobronchial valve treatment. Eur Respir J 2013; 41:302-308.
19. Herzog D, Thomsen C, Poellinger A, Doellinger F, Schreiter N, Froeling V, Schuermann D, Temmesfeld-Wollbruck B, Hippenstiel S, Suttorp N, et al. Outcomes of endobronchial valve treatment based on the precise criteria of an endobronchial catheter for detection of collateral ventilation under spontaneous breathing. Respiration 2016; 91:69-78.
20. Gesierich W, Samitas K, Behr J. Determining collateral ventilation during bronchoscopy: unanswered questions. Thorax 2014;69: 289-290.
21. Donohue JF. Minimal clinically important differences in COPD lung function. COPD 2005;2:111-124.
22. Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, Brusasco V, Burge PS, Calverley PM, Celli BR, et al.; American Thoracic Society; European Respiratory Society Task Force on Outcomes of COPD. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008;31:416-469.
23. Valipour A, Slebos DJ, de Oliveira HG, Eberhardt R, Freitag L, Criner GJ, Herth FJ. Expert statement: pneumothorax associated with endoscopic valve therapy for emphysema: potential mechanisms, treatment algorithm, and case examples. Respiration 2014;87:513-521.
24. Sciurba FC, Rogers RM, Keenan RJ, Slivka WA, Gorcsan J III, Ferson PF, Holbert JM, Brown ML, Landreneau RJ. Improvement in pulmonary function and elastic recoil after lung-reduction surgery for diffuse emphysema. N Engl J Med 1996;334:1095-1099.
25. Weder W, Tutic M, Lardinois D, Jungraithmayr W, Hillinger S, Russi EW, Bloch KE. Persistent benefit from lung volume reduction surgery in patients with homogeneous emphysema. Ann Thorac Surg 2009;87: 229-236; discussion 236-227.
26. Zoumot Z, LoMauro A, Aliverti A, Nelson C, Ward S, Jordan S, Polkey MI, Shah PL, Hopkinson NS. Lung volume reduction in emphysema improves chest wall asynchrony. Chest 2015;148:185-195.
27. Ingenito EP, Wood DE, Utz JP. Bronchoscopic lung volume reduction in severe emphysema. Proc Am Thorac Soc 2008;5:454-460.
28. Pizarro C, Ahmadzadehfar H, Essler M, Tuleta I, Fimmers R, Nickenig G, Skowasch D. Effect of endobronchial valve therapy on pulmonary perfusion and ventilation distribution. PLoS One 2015;10:e0118976.
29. Pizarro C, Schueler R, Hammerstingl C, Tuleta I, Nickenig G, Skowasch D. Impact of endoscopic lung volume reduction on right ventricular myocardial function. PLoS One 2015;10:e0121377.
30. Faisal A, Zoumot Z, Shah PL, Neder JA, Polkey MI, Hopkinson NS. Effective bronchoscopic lung volume reduction accelerates exercise oxygen uptake kinetics in emphysema. Chest 2016;149:435-446.
31. Eberhardt R, Gerovasili V, Kontogianni K, Gompelmann D, Ehlken N, Herth FJ, Grünig E, Nagel C. Endoscopic lung volume reduction with endobronchial valves in patients with severe emphysema and established pulmonary hypertension. Respiration 2015;89:41-48.
32. Park TS, Hong Y, Lee JS, Oh SY, Lee SM, Kim N, Seo JB, Oh YM, Lee SD, Lee SW. Bronchoscopic lung volume reduction by endobronchial valve in advanced emphysema: the first Asian report. Int J Chron Obstruct Pulmon Dis 2015;10:1501-1511.
33. Schuhmann M, Raffy P, Yin Y, Gompelmann D, Oguz I, Eberhardt R, Hornberg D, Heussel CP, Wood S, Herth FJ. Computed tomography predictors of response to endobronchial valve lung reduction treatment: comparison with Chartis. Am J Respir Crit Care Med 2015;191:767-774.
34. Venuta F, Anile M, Diso D, Carillo C, De Giacomo T, D'Andrilli A, Fraioli F, Rendina EA, Coloni GF. Long-term follow-up after bronchoscopic lung volume reduction in patients with emphysema. Eur Respir J 2012;39: 1084-1089.
35. Hopkinson NS, Kemp SV, Toma TP, Hansell DM, Geddes DM, Shah PL, Polkey MI. Atelectasis and survival after bronchoscopic lung volume reduction for COPD. Eur Respir J 2011;37:1346-1351.
36. Fessler HE, Permutt S. Lung volume reduction surgery and airflow limitation. Am J Respir Crit Care Med 1998;157:715-722.
37. Valipour A, Kramer MR, Stanzel F, Kempa A, Asadi S, Fruchter O, Eberhardt R, Herth FJ, Ingenito EP. Physiological modeling of responses to upper versus lower lobe lung volume reduction in homogeneous emphysema. Front Physiol 2012;3:387.
38. Argula RG, Strange C, Ramakrishnan V, Goldin J. Baseline regional perfusion impacts exercise response to endobronchial valve therapy in advanced pulmonary emphysema. Chest 2013;144:1578-1586.
39. Thomsen C, Theilig D, Herzog D, Poellinger A, Doellinger F, Schreiter N, Schreiter V, Schürmann D, Temmesfeld-Wollbrueck B, Hippenstiel S, et al. Lung perfusion and emphysema distribution affect the outcome of endobronchial valve therapy. Int J Chron Obstruct Pulmon Dis 2016;11:1245-1259.
40. Kramer MR, Refaely Y, Maimon N, Rosengarten D, Fruchter O. Bilateral endoscopic sealant lung volume reduction therapy for advanced emphysema. Chest 2012;142:1111-1117.
41. Gompelmann D, Herth FJ, Slebos DJ, Valipour A, Ernst A, Criner GJ, Eberhardt R. Pneumothorax following endobronchial valve therapy and its impact on clinical outcomes in severe emphysema. Respiration 2014;87:485-491.
42. Gompelmann D, Eberhardt R, Herth F. Endoscopic volume reduction in COPD: a critical review. Dtsch Arztebl Int 2014;111:827-833.
43. Friedman PJ. Imaging studies in emphysema. Proc Am Thorac Soc 2008;5:494-500.
44. Gompelmann D, Hofbauer T, Gerovasili V, Eberhardt R, Lim HJ, Herth F, Heussel CP. Predictors of clinical outcome in emphysema patients with atelectasis following endoscopic valve therapy: a retrospective study. Respirology 2016;21:1255-1261.